Anthera Pharmaceuticals, Inc. Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update

biotech jobs post your resume Help employers find you! Check out all the jobs and 

post your resume.

HAYWARD, Calif., Oct. 29, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results, clinical and regulatory update for the quarter ended September 30, 2013.

Third Quarter 2013 Financial Results:

Net loss for the third quarter of 2013 decreased to $5.8 million from $12.0 million, and loss per basic and diluted share decreased to $0.30 from $1.38, as compared to the same quarter in 2012.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC